Back to
UBS Group AG
AGRX
Showing 0 of 4 quarters
Position history for
UBS Group AG's holdings in AGILE THERAPEUTICS INC
No. UBS Group exited its AGRX (Agile Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 1,387 shares worth $2,705. UBS Group first reported AGRX in Q2 2023 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
—
No position history available for this security.